BioCentury
ARTICLE | Clinical News

Bordetella pertussin and parapertussin molecular test regulatory update

September 29, 2008 7:00 AM UTC

Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for Bordetella pertussis and parapertussis. The test is to be performed on the company's MultiCode-RTx real-tim...